What question did this study set out to answer?

This research aims to develop a flow cytometric assay to directly measure platelet activation by thrombin in whole blood using GPRP.

Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial demonstrates a new assay measuring thrombin-induced platelet activation in whole blood, suggesting improved clinical applications.

This research aims to develop a flow cytometric assay to directly measure platelet activation by thrombin in whole blood using GPRP.
Whole blood flow cytometry was utilized to assess platelet activation by thrombin.
The peptide Gly-Pro-Arg-Pro (GPRP) was used to inhibit thrombin-induced fibrin clot formation.
The study reviewed the clinical applications of this new method in arterial thrombosis scenarios.
The assay successfully measured thrombin-induced platelet activation in whole blood context.
GPRP effectively inhibited fibrin clot formation without affecting platelet activation by thrombin.
This method addresses limitations of previous assays, aiding in understanding platelet roles in thrombosis.

Alan D. Michelson (1994) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial demonstrates a new assay measuring thrombin-induced platelet activation in whole blood, suggesting improved clinical applications.